Skip to main content
. 2016 Mar 23;9:1–9. doi: 10.4137/BCI.S36141

Figure 1.

Figure 1

Major enzymatic pathways activated by diabetic hyperglycemia that can impair cellular redox imbalance between NADH and NAD+. The polyol pathway (A) produces NADH, while the ADP-ribosylation pathway (B) can potentially deplete NAD+, accentuating the redox imbalance status between NADH and NAD+.